Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Differential Effects of Iberdomide Versus Revlimid on Leukocyte Trafficking, Immune Activation and DLBCL Tumor Cell Killing

Yumi Nakayama, Hsiling Chiu, Rama K. Narla, Arvind Shakya, Jim Gamez, Isobelle Wall, Despoina Papazoglou, Benedetta Apollonio, Alan G. Ramsay, Patrick Hagner, Anita K Gandhi

Blood (2021) 138 (Supplement 1): 718.

https://doi.org/10.1182/blood-2021-153063

Published: 2021

Journal Articles

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

Blood (2021) 137 (2): 216–231.

https://doi.org/10.1182/blood.2020006073

Published: 2021

Includes: Supplemental data

Journal Articles

Immunocluster: A Computational Tool to Explore the Immune Profile and Cellular Heterogeneity of Hematological Diseases Using Liquid and Imaging Mass, and Flow Cytometry Data

Jessica A. Timms, James W Opzoomer, Kevin Blighe, PhD, Benedetta Apollonio, PhD, Thanos Mourikis, Nicolas Chapuis, PharmD, PhD, Richard Bekoe, Alan G. Ramsay, BSc,MSc,PhD, Donal P. McLornan, MRCP, PhD FRCPath, Claire Harrison, DM, FRCP, FRCPath, Paul R. Barber, Peter Parker, Michaela Fontenay, MD PhD, James N. Arnold, Shahram Kordasti, MD PhD

Blood (2020) 136 (Supplement 1): 9–10.

https://doi.org/10.1182/blood-2020-140258

Published: 2020

Journal Articles

Diffuse Large B-Cell Lymphoma Remodels the Fibroblastic Reticular Network That Acquires Aberrant Immunosuppressive Capabilities; Implications for the Regulation of Anti-Tumor Immunity in the Immuno-Oncology Era

Benedetta Apollonio, PhD, Peter Jarvis, MSc, Beth Phillips, MBBS, FRCPath, BSc, Andrea Kuhnl, Jon Salisbury, Georgios Zacharioudakis, Lesley-Ann Sutton, Richard Rosenquist, MD PhD, Ruth Jarrett, MBBChir, FRCPath, FRCP, Rose-Marie Amini, Anna Vardi, MD PhD, Alan G. Ramsay, BSc,MSc,PhD

Blood (2018) 132 (Supplement 1): 675.

https://doi.org/10.1182/blood-2018-99-116409

Published: 2018

Journal Articles

Extracellular vesicles released by CD40/IL-4–stimulated CLL cells confer altered functional properties to CD4 + T cells

Dawn T. Smallwood, Benedetta Apollonio, Shaun Willimott, Larissa Lezina, Afaf Alharthi, Ashley R. Ambrose, Giulia De Rossi, Alan G. Ramsay, Simon D. Wagner

Blood (2016) 128 (4): 542–552.

https://doi.org/10.1182/blood-2015-11-682377

Published: 2016

Includes: Multimedia, Supplemental data

Journal Articles

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration

Marta Pasikowska, Elisabeth Walsby, Benedetta Apollonio, Kirsty Cuthill, Elizabeth Phillips, Eve Coulter, Maria Serena Longhi, Yun Ma, Deborah Yallop, Linda D. Barber, Piers Patten, Chris Fegan, Alan G. Ramsay, Chris Pepper, Stephen Devereux, Andrea G. S. Buggins

Blood (2016) 128 (4): 563–573.

https://doi.org/10.1182/blood-2016-01-683128

Published: 2016

Includes: Supplemental data

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) Tumor Cells Reprogram Lymphatic Fibroblasts into Cancer-Associated Fibroblasts (CAFs) That Contribute to Tumor Microenvironment (TME)-Driven Immune Privilege

Benedetta Apollonio, PhD, Nicole S. Nicholas, PhD, Lesley-Ann Sutton, Jon Salisbury, Piers E. Patten, BSc, MRCP, MRCPath, PhD, Shireen Kassam, FRCPath, MD MBBS, PhD, Stephen Devereux, FRCP, FRCPath, PhD, Rose Marie Amini, PhD, Richard Rosenquist, Alan G. Ramsay, PhD

Blood (2015) 126 (23): 1474.

https://doi.org/10.1182/blood.V126.23.1474.1474

Published: 2015

Journal Articles

CC-122 Repairs T Cell Activation in Chronic Lymphocytic Leukemia That Results in a Concomitant Increase in PD-1:PD-L1 and CTLA-4 Immune Checkpoint Expression at the Immunological Synapse

Benedetta Apollonio, PhD, Mariam Fanous, BSc, MSc, Mohamed-Reda Benmebarek, BSc, MRes, Stephen Devereux, FRCP, FRCPath, PhD, Patrick Hagner, PhD, Michael Pourdehnad, MD, Anita K. Gandhi, PhD, Piers E. Patten, BSc, MRCP, MRCPath, PhD, Alan G. Ramsay, PhD

Blood (2015) 126 (23): 1738.

https://doi.org/10.1182/blood.V126.23.1738.1738

Published: 2015

Journal Articles

Exosomes and CAFs: partners in crime

Benedetta Apollonio, Alan G. Ramsay

Blood (2015) 126 (9): 1053–1055.

https://doi.org/10.1182/blood-2015-07-655233

Published: 2015

Journal Articles

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, Nikos Papakonstantinou, Maurilio Ponzoni, Charles C. Chu, Davide Rossi, Gianluca Gaidano, Nicholas Chiorazzi, Kostas Stamatopoulos, Paolo Ghia

Blood (2015) 125 (23): 3580–3587.

https://doi.org/10.1182/blood-2014-09-603217

Published: 2015

Includes: Supplemental data

Journal Articles

Anergy in CLL: Moving Towards the Clinic

Benedetta Apollonio, Tania Veliz Rodriguez, Cristina Scielzo, PhD, Maria Teresa Sabrina Bertilaccio, Lydia Scarfò, Federico Caligaris-Cappio, MD, Paolo Ghia, MD PhD

Blood (2014) 124 (21): 4677.

https://doi.org/10.1182/blood.V124.21.4677.4677

Published: 2014

Journal Articles

B-Cell Anergy Underlies Indolent Clinical Behavior Of CLL Stereotyped Subset #4

Stavroula Ntoufa, Nikos Papakonstantinou, Benedetta Apollonio, Maria Gounari, Achilles Anagnostopoulos, MD, Chrysoula Belessi, Marta Muzio, Paolo Ghia, MD, PhD, Kostas Stamatopoulos

Blood (2013) 122 (21): 4115.

https://doi.org/10.1182/blood.V122.21.4115.4115

Published: 2013

Journal Articles

Targeting B-cell anergy in chronic lymphocytic leukemia

Benedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Elisa ten Hacken, Lydia Scarfò, Pamela Ranghetti, Freda Stevenson, Graham Packham, Paolo Ghia, Marta Muzio, Federico Caligaris-Cappio

Blood (2013) 121 (19): 3879–3888.

https://doi.org/10.1182/blood-2012-12-474718

Published: 2013

Includes: Supplemental data

Journal Articles

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia

Elisa ten Hacken, Cristina Scielzo, Maria T. S. Bertilaccio, Lydia Scarfò, Benedetta Apollonio, Federica Barbaglio, Kostas Stamatopoulos, Maurilio Ponzoni, Paolo Ghia, Federico Caligaris-Cappio

Blood (2013) 121 (12): 2264–2273.

https://doi.org/10.1182/blood-2012-09-457119

Published: 2013

Includes: Supplemental data

Journal Articles

Targeting B Cell Anergy in Chronic Lymphocytic Leukemia

Benedetta Apollonio, Cristina Scielzo, Maria Teresa Sabrina Bertilaccio, Elisa ten Hacken, Lydia Scarfò, Paolo Ghia, Marta Muzio, Federico Caligaris-Cappio, MD

Blood (2012) 120 (21): 3863.

https://doi.org/10.1182/blood.V120.21.3863.3863

Published: 2012

Journal Articles

Targeting the LYN/HS1 Signaling Axis in Chronic Lymphocytic Leukemia

Elisa ten Hacken, Cristina Scielzo, Maria Teresa Sabrina Betilaccio, Lydia Scarfò, MD, Benedetta Apollonio, Maurilio Ponzoni, Kostas Stamatopoulos, Paolo Ghia, Federico Caligaris-Cappio, MD

Blood (2012) 120 (21): 928.

https://doi.org/10.1182/blood.V120.21.928.928

Published: 2012

Journal Articles

Bertilaccio MT, Simonetti G, Dagklis A, et al. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood . 2011;118(3): 660–669 .

Maria Teresa Sabrina Bertilaccio, Giorgia Simonetti, Antonis Dagklis, Martina Rocchi, Tania Veliz Rodriguez, Benedetta Apollonio, Alberto Mantovani, Maurilio Ponzoni, Paolo Ghia, Cecilia Garlanda, Federico Caligaris-Cappio, Marta Muzio

Blood (2012) 120 (13): 2773.

https://doi.org/10.1182/blood-2012-08-447797

Published: 2012

Journal Articles

Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models

Blood (2011) 118 (3): 660–669.

https://doi.org/10.1182/blood-2011-01-329870

Published: 2011

Journal Articles

A novel Rag2 −/− γ c −/− -xenograft model of human CLL

Maria Teresa Sabrina Bertilaccio, Cristina Scielzo, Giorgia Simonetti, Maurilio Ponzoni, Benedetta Apollonio, Claudia Fazi, Lydia Scarfò, Martina Rocchi, Marta Muzio, Federico Caligaris-Cappio, Paolo Ghia

Blood (2010) 115 (8): 1605–1609.

https://doi.org/10.1182/blood-2009-05-223586

Published: 2010

Journal Articles

Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells.

Paolo Ghia, MD, PhD, Maria TS Bertilaccio, PhD, Cristina Scielzo, Giorgia Simonetti, Benedetta Apollonio, Claudia Fazi, Marta Muzio, PhD, Maurilio Ponzoni, MD, Federico Caligaris-Cappio, M.D.

Blood (2009) 114 (22): 360.

https://doi.org/10.1182/blood.V114.22.360.360

Published: 2009

NARROW

Differential Effects of Iberdomide Versus Revlimid on Leukocyte Trafficking, Immune Activation and DLBCL Tumor Cell Killing

Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1/PD-1 immunotherapy

Immunocluster: A Computational Tool to Explore the Immune Profile and Cellular Heterogeneity of Hematological Diseases Using Liquid and Imaging Mass, and Flow Cytometry Data

Diffuse Large B-Cell Lymphoma Remodels the Fibroblastic Reticular Network That Acquires Aberrant Immunosuppressive Capabilities; Implications for the Regulation of Anti-Tumor Immunity in the Immuno-Oncology Era

Extracellular vesicles released by CD40/IL-4–stimulated CLL cells confer altered functional properties to CD4 + T cells

Phenotype and immune function of lymph node and peripheral blood CLL cells are linked to transendothelial migration

Diffuse Large B-Cell Lymphoma (DLBCL) Tumor Cells Reprogram Lymphatic Fibroblasts into Cancer-Associated Fibroblasts (CAFs) That Contribute to Tumor Microenvironment (TME)-Driven Immune Privilege

CC-122 Repairs T Cell Activation in Chronic Lymphocytic Leukemia That Results in a Concomitant Increase in PD-1:PD-L1 and CTLA-4 Immune Checkpoint Expression at the Immunological Synapse

Exosomes and CAFs: partners in crime

Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8

Anergy in CLL: Moving Towards the Clinic

B-Cell Anergy Underlies Indolent Clinical Behavior Of CLL Stereotyped Subset #4

Targeting B-cell anergy in chronic lymphocytic leukemia

Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia

Targeting B Cell Anergy in Chronic Lymphocytic Leukemia

Targeting the LYN/HS1 Signaling Axis in Chronic Lymphocytic Leukemia

Bertilaccio MT, Simonetti G, Dagklis A, et al. Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models. Blood . 2011;118(3): 660–669 .

Lack of TIR8/SIGIRR triggers progression of chronic lymphocytic leukemia in mouse models

A novel Rag2 −/− γ c −/− -xenograft model of human CLL

Novel Mouse Models of Chronic Lymphocytic Leukemia (CLL) Unravel the Molecular Mechanisms Controlling Bone Marrow Involvement by Leukemic B Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only